The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion
Name:
s41467-018-05367-2.pdf
Size:
6.132Mb
Format:
PDF
Description:
Final Published version
Author
Padilla-Rodriguez, MarcoParker, Sara S.
Adams, Deanna G.
Westerling, Thomas
Puleo, Julieann I.
Watson, Adam W.
Hill, Samantha M.
Noon, Muhammad
Gaudin, Raphael
Aaron, Jesse
Tong, Daoqin
Roe, Denise J.
Knudsen, Beatrice
Mouneimne, Ghassan
Affiliation
Univ Arizona, BioComp FacilUniv Arizona, Coll Social & Behav Sci, Sch Geog & Dev
Univ Arizona, Ctr Canc
Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth
Issue Date
2018-07-30
Metadata
Show full item recordPublisher
NATURE PUBLISHING GROUPCitation
Padilla-Rodriguez, M., Parker, S. S., Adams, D. G., Westerling, T., Puleo, J. I., Watson, A. W., ... Mouneimne, G. (2018). The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion. Nature Communications, 9(1), [2980]. https://doi.org/10.1038/s41467-018-05367-2Journal
NATURE COMMUNICATIONSRights
© The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Estrogen promotes growth of estrogen receptor-positive (ER+) breast tumors. However, epidemiological studies examining the prognostic characteristics of breast cancer in postmenopausal women receiving hormone replacement therapy reveal a significant decrease in tumor dissemination, suggesting that estrogen has potential protective effects against cancer cell invasion. Here, we show that estrogen suppresses invasion of ER+ breast cancer cells by increasing transcription of the Ena/VASP protein, EVL, which promotes the generation of suppressive cortical actin bundles that inhibit motility dynamics, and is crucial for the ERmediated suppression of invasion in vitro and in vivo. Interestingly, despite its benefits in suppressing tumor growth, anti-estrogenic endocrine therapy decreases EVL expression and increases local invasion in patients. Our results highlight the dichotomous effects of estrogen on tumor progression and suggest that, in contrast to its established role in promoting growth of ER+ tumors, estrogen has a significant role in suppressing invasion through actin cytoskeletal remodeling.ISSN
2041-1723PubMed ID
30061623Version
Final published versionSponsors
Gordon and Betty Moore Foundation; Howard Hughes Medical Institute; NCI grant [RO1 CA196885-01]; Science Foundation Arizona Bisgrove Scholars Postdoctoral Fellowship; NCI University of Arizona Cancer Center Support Grant [P30CA023074]Additional Links
http://www.nature.com/articles/s41467-018-05367-2ae974a485f413a2113503eed53cd6c53
10.1038/s41467-018-05367-2